Cheng Chen

14PUBLICATIONS

14CO-AUTHORS

Molecular targetsMedical infection agents (incl. prions)Humoural immunology and immunochemistryInnate immunityPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 25, 2026

Sequential involvement of hypoxia and anti-PD-1 treatment in shaping tumor-regional CD39<sup>+</sup>CD8<sup>+</sup> T cells highlights immunotherapy-resistant features in NSCLC.

|Jun 24, 2026

Impact of early therapeutic modality on 28-day mortality in immunocompromised patients with opportunistic pulmonary infections: a multicenter retrospective study.

|Sep 09, 2025

Diagnostic and prognostic roles of interferon-λ1 and interferon-λ3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with invasive pulmonary aspergillosis.

Chao Sun, Huanhuan Zhong, Yajie Lu

|May 22, 2025

Development and validation of a machine learning-based diagnostic model for identifying nonneutropenic invasive pulmonary aspergillosis in suspected patients: a multicenter cohort study.

Xinyu Wang, Yajie Lu, Chao Sun

|Jan 29, 2025

Pentraxin-3 as a novel prognostic biomarker in non-neutropenic invasive pulmonary aspergillosis patients.

Chao Sun, Xiaomin Cai, Huanhuan Zhong

|Jan 23, 2025

The imbalance of circulating PD-L1-expressing non-classical/ classical monocytes is involved in immunocompromised host related pulmonary opportunistic infection.

Danhong Zhou, Yujia Jin, Yifan Jin

Pageof 3

Frequent Collaborators

Wenkui Sun

Xin Su

Yu-Jia Jin

Yi-Fan Jin

Yang Wang

Weiwei Ning

Chao Sun

Jiajia Wang

Jiajuan Wu

Jiawei Zhai

Frequent Collaborators

Wenkui Sun

Xin Su

Yu-Jia Jin

Yi-Fan Jin